Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.
Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma. Cancer. 2011 May 15; 117(10):2112-9.
View in:
PubMed
subject areas
Antineoplastic Agents
Carcinoma, Squamous Cell
Child
Cytokines
Dasatinib
Disease-Free Survival
Female
Head and Neck Neoplasms
Humans
Male
Middle Aged
Neoplasm Metastasis
Protein Kinase Inhibitors
Pyrimidines
Thiazoles
authors with profiles
Naoko Takebe